Literature DB >> 25700622

Serotonin Transporter Gene 5-HTTLPR Polymorphism as a Protective Factor Against the Progression of Post-Stroke Depression.

Qiang Zhao1,2, Yi Guo3, Dong Yang4, Tiansong Yang5, Xianghui Meng6.   

Abstract

Polymorphisms in the 5-HTT and BDNF genes are shown to affect their function at the molecular and serum level. Prior work has tried to correlate the polymorphisms with post-stroke depression (PSD), the results nevertheless remain indefinitive. A plausible reason accounting for the uncertainty relates to the small sample of each published trial. In this study, we have performed a comprehensive meta-analysis in order to evaluate the effects of 5-HTT and BDNF polymorphisms (5-HTTLPR, STin2 VNTR, 5-HTR2a 102 T/C, Val66Met) on genetic risk of PSD. Human case-control trials were identified by computer-assisted and manual searches. The article search was performed until October 2014. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using the fixed effects meta-analysis to measure the effects 5-HTT and BDNF polymorphisms exerted on PSD. We also performed test of heterogeneity, test of publication bias, and sensitivity analysis to examine the reliability and stability of combined effects. 5-HTTLPR was clearly associated with genetic risk of PSD. The association seemed to be more pronounced in the homozygous model (OR = 0.34, 95% CI = 0.23-0.51, P(Q-test) = 0.63). Both the heterozygous model and the recessive model showed 50% decreased risk of PSD (OR = 0.50, 95% CI = 0.37-0.67, P(Q-test) = 0.91; OR = 0.50, 95% CI = 0.36-0.70, P(Q-test) = 0.43, respectively). Such significant association was also detected for Caucasian and Asian. These results were reliable and stable based on related analyses. Taken together, 5-HTTLPR polymorphism of the 5-HTT gene seems to protect against the occurrence of PSD. Small sample size for the polymorphisms within 5-HTT and BDNF genes may have caused underestimated associations, and a larger study is required to further assess the relations.

Entities:  

Keywords:  5-HTT; BDNF; Polymorphisms; Post-stroke depression

Mesh:

Substances:

Year:  2015        PMID: 25700622     DOI: 10.1007/s12035-015-9120-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  20 in total

1.  Serotonergic and BDNF genes and risk of depression after stroke.

Authors:  Jae-Min Kim; Robert Stewart; Kyung-Yeol Bae; Sung-Wan Kim; Hee-Ju Kang; Il-Seon Shin; Joon-Tae Kim; Man-Seok Park; Myung-Kyu Kim; Sung-Woo Park; Young-Hoon Kim; Jong-Keun Kim; Ki-Hyun Cho; Jin-Sang Yoon
Journal:  J Affect Disord       Date:  2011-10-20       Impact factor: 4.839

2.  Serotonin transporter gene polymorphism in Chinese patients with poststroke depression: a case-control study.

Authors:  Jing Fang; Weihong Yan; Guo-Xin Jiang; Wei Li; Qi Cheng
Journal:  Stroke       Date:  2011-03-24       Impact factor: 7.914

3.  Frequency of depression after stroke: a systematic review of observational studies.

Authors:  Maree L Hackett; Chaturangi Yapa; Varsha Parag; Craig S Anderson
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

4.  Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders.

Authors:  Jae-Min Kim; Robert Stewart; Sung-Wan Kim; Su-Jin Yang; Il-Seon Shin; Young-Hoon Kim; Jin-Sang Yoon
Journal:  Biol Psychiatry       Date:  2007-05-04       Impact factor: 13.382

5.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

6.  Blunted prolactin response to D-fenfluramine in post-stroke major depression.

Authors:  Philip Morris; Malcolm Hopwood; Kay Maguire; Trevor Norman; Isaac Schweitzer
Journal:  J Affect Disord       Date:  2003-09       Impact factor: 4.839

7.  Developmental alterations in anxiety and cognitive behavior in serotonin transporter mutant mice.

Authors:  Yasufumi Sakakibara; Yoshiyuki Kasahara; F Scott Hall; Klaus-Peter Lesch; Dennis L Murphy; George R Uhl; Ichiro Sora
Journal:  Psychopharmacology (Berl)       Date:  2014-04-13       Impact factor: 4.530

8.  Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety.

Authors:  J M Gatt; C B Nemeroff; C Dobson-Stone; R H Paul; R A Bryant; P R Schofield; E Gordon; A H Kemp; L M Williams
Journal:  Mol Psychiatry       Date:  2009-01-20       Impact factor: 15.992

9.  Serotonin transporter gene promoter region polymorphism associated with poststroke major depression.

Authors:  Rajamannar Ramasubbu; Rose Tobias; Alastair M Buchan; N Torben Bech-Hansen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2006       Impact factor: 2.198

10.  Meta-analysis of molecular imaging of serotonin transporters in major depression.

Authors:  Gregor Gryglewski; Rupert Lanzenberger; Georg S Kranz; Paul Cumming
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-07       Impact factor: 6.200

View more
  3 in total

1.  Association of post stroke depression with social factors, insomnia, and neurological status in Chinese elderly population.

Authors:  Lingru Wang; Yong Tao; Yang Chen; Hua Wang; Huadong Zhou; Xiaoyan Fu
Journal:  Neurol Sci       Date:  2016-04-27       Impact factor: 3.307

2.  Apolipoprotein E polymorphisms increase the risk of post-stroke depression.

Authors:  Xue-Bin Li; Jie Wang; An-Ding Xu; Jian-Min Huang; Lan-Qing Meng; Rui-Ya Huang; Jun-Li Wang
Journal:  Neural Regen Res       Date:  2016-11       Impact factor: 5.135

3.  Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression.

Authors:  Amin Zahrai; Faranak Vahid-Ansari; Mireille Daigle; Paul R Albert
Journal:  Transl Psychiatry       Date:  2020-09-30       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.